• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
College of Medicine: Department of Biochemistry and Molecular Biology
  • UAMS Health
  • Jobs
  • Giving
  • About Us
    • News
  • Faculty/Staff
    • Primary Faculty
    • Secondary Faculty
    • Adjunct Faculty
    • Professor Emeritus
    • Track Members
    • Research and Administrative Staff
  • Research Areas
    • Cancer Biology
    • Experimental Therapeutics
    • Systems Biology and Bioinformatics
      • Systems Biology News
    • Structural Biology and Enzymology
    • Nutrition and Metabolism
    • Chromatin Biology, Nucleic Acid Chemistry, and Genetics
    • Neurobiology and Neurobiochemistry
  • Students
    • Graduate Program
    • Elective Courses
    • Student Highlight
    • Alumni
      • Graduates
      • Where Are They Now?
    • Grant Opportunities
    • Career Information
    • Resources for Current Students
    • Resilience
    • About the Area
  • Seminars
    • Faculty Seminars
    • Student Seminars
    • Webinars and Conferences
  • Undergraduate Programs
    • Summer Research
      • Program Details
      • Application Materials
      • Research Opportunities
      • Information for Participants
      • Prior Participants
      • SURF Related Publications
      • Contact Information
      • Frequently Asked Questions
    • Arkansas Undergraduate Summer Research Symposium
      • Details
      • Registration
      • Directions and Parking
      • Top Presentations
      • Contact
  • Research Resources
  1. University of Arkansas for Medical Sciences
  2. College of Medicine
  3. Department of Biochemistry and Molecular Biology
  4. News
  5. $1.9 Million Grant Funds DNA Damage Research by Justin Leung, Ph.D.

$1.9 Million Grant Funds DNA Damage Research by Justin Leung, Ph.D.

By Susan Van Dusen

A $1.9 million grant from the National Institute of General Medical Studies (NIGMS) will allow a scientist at the University of Arkansas for Medical Sciences (UAMS) to advance his research of DNA damage response (DDR) in cancer and genetic disorders.

Justin Leung, Ph.D., received the five-year grant for his project titled “Deciphering the Chromatin-based DNA Damage Response Pathway.” NIGMS, a part of the National Institutes of Health, supports basic research that improves understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment and prevention. ​

“DNA damage is a constant threat to our genetic material, so our bodies evolved a surveillance system called the DDR pathway. This pathway maintains our genome integrity by protecting our cells from damage to the genetic information that results in mutations and cell malignancies,” said Leung, assistant professor in the UAMS College of Medicine Department of Radiation Oncology and researcher in the UAMS Winthrop P. Rockefeller Cancer Institute.

An intact DDR pathway and network of DNA-repair proteins are essential for maintaining genome stability. When any component of the DDR pathway is compromised, DNA mutations will accumulate in cells, which potentially lead to diseases including cancer and genetic disorders.

“Our lab aims to understand how cells precisely repair DNA damage at the right place and right time. We investigate how the DDR is initiated and the mechanism by which DNA repair proteins are brought to the DNA breaks,” Leung said.

Leung’s grant, known as an R35 Maximizing Investigators’ Research Award, will be used to build a roadmap of the chromatin-based DDR pathway. The study will potentially provide insight into the causes of cancer and DDR-related genetic diseases. It will also help to develop therapeutic strategies for cancer treatment.

Research Findings Published

Findings from a collaborative project on DNA damage response conducted by Leung and Michael Huen, Ph.D., of the University of Hong Kong, was published July 1 in the scientific journal PNAS (Proceedings of the National Academy of Sciences of the United States of America).

The article titled “Screen identifies DYRK1B network as mediator of transcription repression on damaged chromatin,” outlines the team’s identification of a protein called DYRK1B and its functional network as a new branch of the DNA damage response to protect our genetic materials.

“Our work explains how DYRK1B dysregulation may fuel cancer progression. It also guides the development of a therapeutic strategy for the treatment of cancer and several rare genome instability-associated diseases,” Leung said.

The study uses a comprehensive proteomics approach supported by the IDeA (Institutional Development Award) National Resource for Quantitative Proteomics at UAMS to build an atlas for DYRK1B functions through profiling the potential biological pathways in which DYRK1B is involved.

“This study will open up new avenues for scientific discovery to study not only DNA repair but also a wide range of protein modifications in diverse cellular functions,” Leung said.

Postdoctoral fellow Kirk West, Ph.D., is the UAMS author of the study.

Posted by Chris Lesher on September 9, 2020

Filed Under: Department News

UAMS College of Medicine LogoUAMS College of MedicineUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2025 University of Arkansas for Medical Sciences